Cover image not available

Donepezil, galantamine, rivastigmine and memantne for the treatment of Alzheimer's disease : Review of NICE technology appraisal guidance 111

National Institute for Health and Clinical Excellence

Publication Data

Title Donepezil, galantamine, rivastigmine and memantne for the treatment of Alzheimer's disease : Review of NICE technology appraisal guidance 111
Author National Institute for Health and Clinical Excellence
Publisher National Institute for Health and Clinical Excellence
Publication date 2011
Publication location London
Language English

Descriptive Notes

Issue date: March 2011 ; Review date: April 2014.
"This guidance replaces NICE technology appraisal guidance 111 issued in November 2006 (amended September 2007, August 2009)."

Topics

Alzheimer's disease :: Chemotherapy :: England
Alzheimer's disease :: Chemotherapy :: Wales
Acetylcholinesterase
Alkaloids
Parasympathomimetic agents
Glutamic acid

Catalogue Data

OBNB ID GBB586205
ISBN 10 n/a
ISBN 13 n/a
Type BibliographicResource, Book
Dewey Classification 616.831061

ISBD

P1053 1 online resource (84 pages).
P1042 Includes bibliographical references.

Buy a copy

OBNB doesn't sell books, but you may be able to find a copy at one of these websites:

Donepezil, galantamine, rivastigmine and memantne for the treatment of Alzheimer's disease : Review of NICE technology appraisal guidance 111 by National Institute for Health and Clinical Excellence. Published by National Institute for Health and Clinical Excellence in 2011. Publication and catalogue information, links to buy online and reader comments.